CTXR vs MCO · rev $7.1M vs P/E 33, rev $4.26B
Citius Pharmaceuticals Inc (CTXR) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
CTXR currently screens at market cap $13.4M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the CTXR and MCO stock pages for the full models.
Not investment advice.